Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Yale Center for Clinical Investigation: leveraging industry partnerships and research cores.

Sherwin R, Slayman C, Rockwell S, Herold K, Williams K, Carson R, Mane S, Seow H, Max J, Johnson T.

Clin Transl Sci. 2012 Dec;5(6):435-6. doi: 10.1111/cts.12016. No abstract available.

PMID:
23253663
2.

Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.

Grossi AB, Leifsson PS, Jensen HE, Vainer B, Iburg T.

Vet Pathol. 2013 May;50(3):534-42. doi: 10.1177/0300985812469638. Epub 2012 Dec 14.

3.

Variability of global left ventricular deformation analysis using vendor dependent and independent two-dimensional speckle-tracking software in adults.

Risum N, Ali S, Olsen NT, Jons C, Khouri MG, Lauridsen TK, Samad Z, Velazquez EJ, Sogaard P, Kisslo J.

J Am Soc Echocardiogr. 2012 Nov;25(11):1195-203. doi: 10.1016/j.echo.2012.08.007. Epub 2012 Sep 12.

PMID:
22981228
4.

Effect of a novel vendor-specific motion-correction algorithm on image quality and diagnostic accuracy in persons undergoing coronary CT angiography without rate-control medications.

Leipsic J, Labounty TM, Hague CJ, Mancini GB, O'Brien JM, Wood DA, Taylor CM, Cury RC, Earls JP, Heilbron BG, Ajlan AM, Feuchtner G, Min JK.

J Cardiovasc Comput Tomogr. 2012 May-Jun;6(3):164-71. doi: 10.1016/j.jcct.2012.04.004. Epub 2012 Apr 6.

PMID:
22551593
5.

Public-private partnerships in translational medicine: concepts and practical examples.

Luijten PR, van Dongen GA, Moonen CT, Storm G, Crommelin DJ.

J Control Release. 2012 Jul 20;161(2):416-21. doi: 10.1016/j.jconrel.2012.03.012. Epub 2012 Mar 20. Review.

PMID:
22465390
6.

Qualification of imaging biomarkers for oncology drug development.

Waterton JC, Pylkkanen L.

Eur J Cancer. 2012 Mar;48(4):409-15. doi: 10.1016/j.ejca.2011.11.037. Epub 2012 Jan 5. Review.

PMID:
22226478
7.

A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging.

Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC; Group.

Radiology. 2011 Mar;258(3):906-14. doi: 10.1148/radiol.10100799.

PMID:
21339352
8.

Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities.

Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC, Aerts HJ, Bendriem B, Bendtsen C, Boellaard R, Boone JM, Cole PE, Conklin JJ, Dorfman GS, Douglas PS, Eidsaunet W, Elsinger C, Frank RA, Gatsonis C, Giger ML, Gupta SN, Gustafson D, Hoekstra OS, Jackson EF, Karam L, Kelloff GJ, Kinahan PE, McLennan G, Miller CG, Mozley PD, Muller KE, Patt R, Raunig D, Rosen M, Rupani H, Schwartz LH, Siegel BA, Sorensen AG, Wahl RL, Waterton JC, Wolf W, Zahlmann G, Zimmerman B.

Radiology. 2011 Jun;259(3):875-84. doi: 10.1148/radiol.10100800. Epub 2011 Feb 15.

PMID:
21325035
9.

Standardization of quantitative imaging: the time is right, and 18F-FDG PET/CT is a good place to start.

Buckler AJ, Boellaard R.

J Nucl Med. 2011 Feb;52(2):171-2. doi: 10.2967/jnumed.110.081224. Epub 2011 Jan 13. No abstract available.

10.

Data sets for the qualification of volumetric CT as a quantitative imaging biomarker in lung cancer.

Buckler AJ, Schwartz LH, Petrick N, McNitt-Gray M, Zhao B, Fenimore C, Reeves AP, Mozley PD, Avila RS.

Opt Express. 2010 Jul 5;18(14):15267-82. doi: 10.1364/OE.18.015267.

PMID:
20640013
11.

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.

Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K.

Nat Rev Drug Discov. 2010 Jul;9(7):560-74. doi: 10.1038/nrd3115. Review.

PMID:
20592748
12.

Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence.

Mozley PD, Schwartz LH, Bendtsen C, Zhao B, Petrick N, Buckler AJ.

Ann Oncol. 2010 Sep;21(9):1751-5. doi: 10.1093/annonc/mdq051. Epub 2010 Mar 23. Review.

13.

Volumetric CT in lung cancer: an example for the qualification of imaging as a biomarker.

Buckler AJ, Mozley PD, Schwartz L, Petrick N, McNitt-Gray M, Fenimore C, O'Donnell K, Hayes W, Kim HJ, Clarke L, Sullivan D.

Acad Radiol. 2010 Jan;17(1):107-15. doi: 10.1016/j.acra.2009.06.019.

PMID:
19969254
14.

The use of volumetric CT as an imaging biomarker in lung cancer.

Buckler AJ, Mulshine JL, Gottlieb R, Zhao B, Mozley PD, Schwartz L.

Acad Radiol. 2010 Jan;17(1):100-6. doi: 10.1016/j.acra.2009.07.030. Review.

PMID:
19969253
15.

Commercially available computer-aided detection system for pulmonary nodules on thin-section images using 64 detectors-row CT: preliminary study of 48 cases.

Yanagawa M, Honda O, Yoshida S, Ono Y, Inoue A, Daimon T, Sumikawa H, Mihara N, Johkoh T, Tomiyama N, Nakamura H.

Acad Radiol. 2009 Aug;16(8):924-33. doi: 10.1016/j.acra.2009.01.030. Epub 2009 Apr 25.

PMID:
19394873
16.

Small animal imaging facility: new perspectives for the radiologist.

Grassi R, Cavaliere C, Cozzolino S, Mansi L, Cirillo S, Tedeschi G, Franchi R, Russo P, Cornacchia S, Rotondo A.

Radiol Med. 2009 Feb;114(1):152-67. doi: 10.1007/s11547-008-0352-8. Epub 2008 Dec 11. Review. English, Italian.

PMID:
19082783
17.

Medical integrity up in smoke? Conflicts of interest and the lung cancer screening controversy.

Moy B.

Oncologist. 2008 May;13(5):474-6. doi: 10.1634/theoncologist.2008-0098. No abstract available.

18.

Tar-nished reputations.

[No authors listed]

Lancet Oncol. 2008 May;9(5):401. doi: 10.1016/S1470-2045(08)70108-6. No abstract available.

PMID:
18452846
19.

Biomarkers in drug discovery and development.

Bakhtiar R.

J Pharmacol Toxicol Methods. 2008 Mar-Apr;57(2):85-91. Epub 2007 Oct 23. Review.

PMID:
18024093
20.

Evidence isn't everything. Even the best purchasing practices vulnerable.

DoBias M.

Mod Healthc. 2007 Apr 23;37(17):32-3. No abstract available.

PMID:
17477202
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk